| 1 |
31686175 | Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects. | 2020 Jan |
1 |
| 2 |
30248622 | An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds. | 2018 Nov |
1 |
| 3 |
25870334 | Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor. | 2015 Jul |
1 |
| 4 |
22931533 | Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease. | 2013 Mar |
2 |
| 5 |
20930482 | [Beneficial effect of galantamine on sensory information-processing deficits]. | 2010 Oct |
1 |
| 6 |
18325740 | High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. | 2008 Jul |
1 |
| 7 |
17481657 | Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors. | 2007 Jun 15 |
1 |
| 8 |
17632185 | Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission. | 2007 Sep |
1 |
| 9 |
17656829 | Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology. | 2007 Jul |
1 |
| 10 |
18221220 | Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor. | 2007 Jun |
1 |
| 11 |
15639548 | Indicators of neuroprotection with galantamine. | 2005 Jan 30 |
1 |
| 12 |
15834443 | Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity. | 2005 Jul |
2 |
| 13 |
15937519 | Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells. | 2005 Aug |
4 |
| 14 |
12649296 | Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. | 2003 Jun |
3 |
| 15 |
14573772 | The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release. | 2003 Nov |
2 |
| 16 |
12417371 | The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. | 2002 Nov 15 |
1 |
| 17 |
11669505 | Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. | 2001 Aug |
1 |
| 18 |
10971047 | Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease. | 2000 Sep |
2 |
| 19 |
11261808 | Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR. | 2000 |
3 |